Science can and does change humanity. Yet while we live in an age of extraordinary advances, profound health challenges remain. Global health emergencies such as rapidly rising drug-resistance, epidemic threats from diseases known and unknown, mental health, and the escalating climate crisis are a threat to us all.
A fridge designed for vaccines and medicines has “harnessed the power of nature” to keep its contents cold, even with intermittent access to electricity.
Substandard and falsified medications pose significant risks to global health. Nearly one in five antimalarials circulating in low- and middle-income countries are substandard or falsified. We assessed the health and economic impact of substandard and falsified antimalarials on children under five in Nigeria, where malaria is endemic and poor-quality medications are commonplace.
This Thursday (25 April) is World Malaria Day and we hope you’ll join us in calling for #MedsWeCanTrust. If you or your organization would be willing to share social media content on this topic, please see our #WorldMalariaDay social media toolkit for suggested language and graphics.
Quality assurance of medicines supplied to low income and middle-income countries: poor products in shiny boxes?
In today's context of globalisation of pharmaceutical production and distribution, international and national procurement agencies play a de facto key role in defining the quality of medicines available in sub-Saharan Africa.
Over the past few weeks since the World Health Assembly, we’ve seen quality integrated into seminal reports and WHO action plans on antimicrobial resistance (AMR), drug procurement and universal health coverage (UHC). We’re excited to see links made across these issues.
The prevalence of poor-quality antimicrobial medicines is widespread throughout Africa and Asia in lower income countries and lower middle-income countries.
Falciparum malaria kills, and it particularly kills the rural poor. Artemisinin derivatives, such as artesunate, are a vital component of Plasmodium falciparum malaria treatment and control in the face of globally increasing antimalarial drug resistance.